Laboratory Testing for SIBO
Order a combined hydrogen-methane breath test using glucose as the substrate as your first-line diagnostic test for suspected SIBO. 1, 2
Primary Diagnostic Test: Breath Testing
Combined hydrogen-methane breath testing is the recommended initial diagnostic approach because hydrogen-only testing misses approximately one-third of cases where patients produce methane instead of hydrogen. 1, 3
Substrate Selection
- Glucose breath testing is preferred over lactulose due to higher specificity (86-92% vs 44-100%) and fewer false positives from rapid transit. 1, 4, 5
- Glucose testing has better agreement with jejunal aspirate culture (κ = 0.659) compared to lactulose (κ = 0.588). 5
- Lactulose testing produces false positives when rapid transit delivers substrate to the colon (mean transit ~73 minutes), making the test measure colonic fermentation rather than small bowel overgrowth. 6, 7
Why Measure Both Gases
- Methane-producing organisms are present in approximately 30% of adults, so hydrogen-only testing yields 5-15% false negatives. 3
- Some patients produce exclusively methane at the expense of hydrogen through microbial conversion of CO2. 3
- Combined testing increases overall sensitivity for detecting SIBO. 1, 4
Second-Line Test: Small Bowel Aspirate
If breath testing is unavailable or inconclusive, obtain small bowel aspirate via endoscopy with quantitative culture. 2
Proper Collection Technique
- Flush the endoscope channel with sterile saline and air before aspiration to avoid oropharyngeal contamination. 2
- Aspirate fluid into a sterile trap. 2
- Send for both aerobic and anaerobic cultures to maximize pathogen detection. 7
Diagnostic Threshold
- Bacterial concentration >10⁵ CFU/mL defines clinically significant overgrowth (normal is <10⁴ CFU/mL). 7, 8
- The most frequently isolated organisms are Bacteroides, Enterococcus, and Lactobacillus species. 7
Limitations of Aspirate Culture
- Cannot culture many clinically relevant anaerobic organisms with standard techniques. 7
- Sampling error—a single aspirate cannot represent the entire small intestine. 7
- Oropharyngeal contamination produces false positives. 7
- High cost, invasive nature, and lack of standardization limit routine use. 4
Additional Laboratory Screening
Screen for malabsorption of fat-soluble vitamins (A, D, E, K) and vitamin B12 because bacterial overgrowth causes deconjugation of bile salts. 1, 2
Specific Monitoring
- Vitamin D deficiency occurs in approximately 20% of patients, particularly those on bile-acid sequestrants. 7
- Check fecal elastase if symptoms persist after SIBO eradication to evaluate for pancreatic exocrine insufficiency. 7
- Note that falsely low fecal elastase can occur secondary to diarrhea itself. 1
When to Skip Testing and Treat Empirically
Proceed directly to empirical antibiotic therapy without testing in patients with high pretest probability, specifically those with: 7
- Documented pseudo-obstruction or dysmotility disorders
- Prior small bowel surgery or anatomical abnormalities
- Small bowel diverticulosis
- Stricturing or fistulizing Crohn's disease (up to 30% prevalence of SIBO)
- Loss of ileocecal valve
However, testing is generally preferred over empirical treatment to establish the diagnosis, support antibiotic stewardship, and avoid treating resistant organisms or misdiagnosed conditions. 1, 7
Critical Pitfalls to Avoid
- Do not use lactose, fructose, or sorbitol as breath test substrates—these assess carbohydrate malabsorption, not SIBO. 4
- A negative breath test does not rule out SIBO—sensitivity ranges only 31-68% for lactulose and 20-93% for glucose. 1, 7
- Rapid transit produces false-positive breath tests by delivering substrate to the colon prematurely; interpret positive results cautiously and correlate clinically. 7
- 3-25% of patients produce neither hydrogen nor methane, resulting in false-negative tests despite true bacterial overgrowth. 7
- Maintain higher suspicion for SIBO in patients on opioids or proton-pump inhibitors despite test limitations. 7